ProCE Banner Activity

Optimizing Frontline Treatment for MCL: Considerations for BTK Inhibitors in Older Patients

Slideset

Download these slides to learn about the current treatment recommendations and up-to-date data on using a BTK inhibitor as initial therapy for older patients with mantle cell lymphoma (MCL).

Released: December 05, 2024

Expiration: December 04, 2025

Share

Faculty

John P. Leonard

John P. Leonard, MD

Senior Associate Dean for Innovation and Initiatives
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine
NewYork-Presbyterian
New York, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca